Position in RYTM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$146,950,685
-$35,693,485 QoQ
Shares Held
1,689,671
-1.0% QoQ
Ownership
2.47%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.60584042692335.ToString("F0")%
Shared 0.ToString("F0")%
None 0.39415957307665217.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. RYTM ranks #66 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in RYTM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $146,950,685 | 1,689,671 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $182,644,170 | 1,706,317 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $216,642,030 | 2,145,183 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $123,437,935 | 1,953,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $89,433,222 | 1,688,375 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,331,841 | 113,109 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,634,954 | 50,295 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,149,228 | 27,989 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,257,436 | 29,020 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $24,324,105 | 529,130 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,909,766 | 868,474 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,568,294 | 701,534 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,467,020 | 698,824 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $22,510,575 | 773,028 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $33,588,226 | 1,370,948 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,311,525 | 556,994 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,380,547 | 553,867 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,452,273 | 546,320 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,087,610 | 83,278 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $1,630,583 | 83,278 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,771,323 | 83,278 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,402,601 | 47,178 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,313,158 | 60,598 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,041,539 | 226,078 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,440,907 | 226,078 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||